Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04785443 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy

Study acronym: HYPOCAAVI
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 19, 2026 (before its estimated June 22, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 2024 to Jun 22, 2026
    • Study completion date: Mar 2025 to Jun 22, 2027
    v8
  2. 3 versions Re-verified since Jun 29, 2022, no change to tracked fieldsv5-v7
  3. Primary completion date: Jul 2024 to Jun 2024
    • Study completion date: Apr 2025 to Mar 2025
    • Start date changed from estimate of Jul 2021 to Jun 22, 2021
    v4
  4. Start date: May 2021 to Jul 2021
    • Primary completion date: May 2024 to Jul 2024
    • Study completion date: Jan 2025 to Apr 2025
    • Site contact updated
    v3
  5. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Apr 2024 to May 2024
    • Study completion date: Dec 2024 to Jan 2025
    • Start date: Apr 2021 to May 2021
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
* Hypoparathyroidism is the most common complication after a total thyroidectomy surgery. It becomes permanent after 6 months. * Untreated permanent hypoparathyroidism is a source of numerous complications in general and therefore requires lifelong replacement therapy resulting in a significant deterioration in quality of life. * The intraoperative use of indocyanine green (ICG) angiography has recently been described as a reliable means of detecting parathyroidism and predicting the risk of postoperative hypoparathyroidism. * This use could prove to be a way to preserve parathyroid in vivo and thus reduce post-operative hypoparathyroidism rates.
Trial Details
NCT Number NCT04785443
Lead Sponsor University Hospital, Brest
Conditions
(from sponsor)		 Thyroid Diseases
Related terms Hypocalcemia, Hypoparathyroidism, Thyroid Diseases
Enrollment 242 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov